India’s Hetero pulls heart drug from U.S. amid cancer risk probes



A unit of India’s Hetero Drugs is recalling some batches of the blood pressure and heart medicine valsartan in the United States, a notice on the U.S. regulator’s website said, amid a wider probe into cancer risks associated with the drug.





Source link

Be the first to comment

Leave a Reply

Your email address will not be published.


*